Related Experiment Video
Updated: Jun 11, 2025

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
Published on: August 11, 2023
Exploring Factors Influencing Stroke Risk: Insights From a Predictive Analysis
Venkatram Murugesan1, Murugesan Natesan1, Vahidha Sulthana1
1Nephrology, East Coast Hospitals, Pondicherry, IND.
Insights
This study found that while higher fasting insulin levels may reduce stroke risk, increased postprandial insulin and age are associated with a higher risk. These findings highlight the complex role of insulin in stroke occurrence.
Area of Science:
- Endocrinology
- Neurology
- Cardiovascular Medicine
Background:
- Stroke is a leading cause of disability and mortality globally, with numerous modifiable and non-modifiable risk factors.
- Understanding the intricate relationship between metabolic markers, such as insulin levels, and stroke occurrence is crucial for effective prevention strategies.
Purpose of the Study:
- To investigate the association between fasting and postprandial insulin levels and stroke occurrence in a cohort of 229 patients.
- To identify key predictors of stroke risk within the studied population.
Main Methods:
- Retrospective analysis of clinical data from 229 patients, including demographic information, medical history, and various blood glucose and insulin measurements.
- Logistic regression analysis was employed to model the relationship between insulin levels, age, and stroke occurrence, accounting for an imbalanced outcome variable.
Main Results:
- Increasing postprandial insulin levels and age were significantly associated with an increased risk of stroke.
- Conversely, higher fasting insulin levels were linked to a reduced risk of stroke.
- Blood glucose, cholesterol, and triglyceride levels demonstrated minor associations with stroke occurrence, with higher total cholesterol and triglycerides showing a slight association with lower stroke risk.
Conclusions:
- Age and postprandial insulin levels are identified as significant risk factors for stroke.
- Fasting insulin levels may play a protective role, warranting further investigation.
- Additional research with larger sample sizes is recommended to validate these findings and elucidate the complex role of insulin in stroke pathophysiology.
Abstract:
Introduction Stroke is a serious medical condition characterized by the sudden interruption of blood flow to the brain, resulting in the death of brain cells. It is a leading cause of long-term disability and mortality worldwide. Stroke has some associated risk factors, both modifiable and non-modifiable ones. As for non-modifiable risk factors, these are age, gender (men are more vulnerable), and family history of stroke. The controllable or adjustable risk factors include hypertension (high blood pressure), diabetes, smoking, high cholesterol levels, obesity, and insulin resistance. Methods In our study, we collected data from 229 patients which were originally collected for clinical purposes and were retrospectively analyzed. These data contain features such as sex and age, the presence of ischemic heart disease (IHD) or stroke history, and different blood sugar readings. These measurements include fasting blood sugar (FBS), postprandial blood sugar (PPBS), HbA1c%, and insulin levels (fasting and postprandial). Furthermore, cholesterol was also tested, such as total cholesterol, triglycerides (TGL), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL). Surprisingly, stroke was observed in 24 of the 205 patients. This contrast permits us to be concerned with the chance of the association between stroke and insulin levels. Given the imbalanced nature of our outcome variable (stroke occurrence), the primary analytical method will be logistic regression. Results In this cross-sectional study, we investigated the association between high insulin levels (both fasting and postprandial) and the occurrence of stroke within a dataset of 229 patients. Out of the 229 included cases, 102 individuals were female (44.5%) and 127 individuals were male (55.5%). Twenty-four cases have ischemic heart disease (10.5%). Among the analyzed cases, 24 individuals have a history of stroke. The average age of the sample is approximately 57 years ± 14.87. There was no significant difference between the males and females in most of the descriptive statistics. However, females experienced significantly higher levels of postprandial glucose level and significantly lower levels of postprandial insulin. According to our predictive model, we found that an increase in fasting insulin levels was linked to a lower risk of stroke occurrence. On the other hand, increasing insulin postprandial levels and age were associated with an increased risk of stroke. Conclusion Our study identified age, fasting insulin, and postprandial insulin as key factors influencing stroke risk. Higher fasting insulin levels were associated with reduced risk, while increased postprandial insulin and age were linked to higher risk. Blood glucose, cholesterol, and triglycerides had minor effects. Notably, higher total cholesterol and triglyceride levels were slightly associated with lower stroke occurrence. Further research with larger samples is needed for validation.
Related Concept Videos
Factors affecting Blood pressure
Physiological Factors:
Coronary Artery Disease I: Introduction
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Atherosclerosis II: Clinical manifestations and prevention

